AMBRY GENETICS

In News

Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution” - Business Wire

Business Wire - May 11, 2026

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era - The Cancer Letter

The Cancer Letter - Mar 04, 2026

Ambry Genetics Reaches 1 Million RNA-Enhanced Genetic Tests - Clinical Lab Products

Clinical Lab Products - Feb 02, 2026

RNA in cancer gene tests found 1 in 25 positives otherwise missed - Stock Titan

Stock Titan - Feb 02, 2026

Collate Emphasizes Biotech Data Governance and AI Use Case With Ambry Genetics Example - TipRanks

TipRanks - May 01, 2026

Tempus AI’s Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool - Yahoo Finance

Yahoo Finance - Jun 29, 2025

More than a year after negative genetic test, new findings give family long-sought diagnosis - MPR News

MPR News - Nov 30, 2025

AI Health Co. Illegally Shared Genetic Data, Patients Say - Law360

Law360 - Apr 17, 2026

Ambry Genetics Expands MAVE Research to PALB2 Gene for Hereditary Cancer Testing - Clinical Lab Products

Clinical Lab Products - Feb 04, 2026

Healthcare Tech Firm Hit With Class Action for Allegedly Stealing Genetic Data to Train AI Models - Law.com

Law.com - Feb 20, 2026

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density - Business Wire

Business Wire - Oct 01, 2025

Why Tempus AI Stock Was Motoring Higher This Week - The Motley Fool

The Motley Fool - Oct 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment